Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns
Article
[키워드] ACE2
acute respiratory syndrome
Analysis
angiotensin receptor blocker
angiotensin-converting enzyme 2
Anticoagulant
antihypertensive agents
Arterial hypertension
Asturia
caused
clinical
Clinical management
clinical manifestation
Cohort
Comorbidities
Comorbidity
concern
contrary
coronavirus
Coronavirus disease 2019
Corticosteroid
Corticosteroids
covariates
COVID-19
COVID-19 patient
COVID-19 patients
Cox regression
Demographic variables
detrimental
diabete
Effectiveness
hospitalized patient
hospitalized patients
immune response
Impact
IMPROVE
Inflammation
inhibitor
LMWH
low molecular weight
management
non-steroidal anti-inflammatory drug
NSAIDS
patients
pro-thrombotic
propensity score matching
reported
Retrospective study
Risk factors
SARS-CoV-2
significantly
Spanish
specific treatment
survival
Survival curves
thrombosis
Thrombosis prophylaxis
Treatment
treatment arm
while
[DOI] 10.3390/jcm10051073 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10051073 PMC 바로가기 [Article Type] Article